North America Next Generation Sequencing (NGS) Market Size, Share, Trends, Industry Analysis and Forecast by 2030

“North America Next Generation Sequencing (NGS) Market Summary:

According to the latest report published by Data Bridge Market Research, the North America Next Generation Sequencing (NGS) Market

CAGR Value

Data Bridge Market Research analyzes that the North America next generation sequencing (NGS) market, which was USD 3489.40 million in 2022, will reach USD 15615.61 million by 2030 and is expected to undergo a CAGR of 17.4% during the forecast period.

Credible North America Next Generation Sequencing (NGS) Market business report comprises of fundamental, secondary and advanced information related to the global status, recent trends, market size, sales volume, market share, growth, future trends analysis, segment and forecasts . Best practice models and research methodologies are employed in the business report to present comprehensive market analysis with correct market segmentation and insights. Businesses can confidently rely upon this top-quality market report to accomplish an utter success. North America Next Generation Sequencing (NGS) Market analysis gives an examination of various segments that are relied upon to witness the quickest development amid the estimated forecast frame.

Stay informed with our latest keyword market research covering strategies, innovations, and forecasts. Download full report: https://www.databridgemarketresearch.com/reports/north-america-next-generation-sequencing-ngs-market

North America Next Generation Sequencing (NGS) Market Segmentation and Market Companies

Segments

The North America Next Generation Sequencing (NGS) market is segmented based on technology, application, and end user. In terms of technology, Sequencing by Synthesis (SBS) holds a significant market share due to its high accuracy and cost effectiveness. Ion Semiconductor Sequencing is also gaining popularity in the market. When it comes to applications, diagnostics is the leading segment as NGS technology is widely used for disease diagnosis and personalized treatment. Drug discovery and biomarker discovery are also crucial applications driving market growth. Academic and research institutes are the primary end users of NGS technology, followed by hospitals and clinics, pharmaceutical and biotechnology companies.

Market Players

The North America Next Generation Sequencing (NGS) market is highly competitive with key players such as Illumina, Inc., Thermo Fisher Scientific Inc., and Pacific Biosciences of California, Inc. dominating the market share. These companies invest heavily in research and development to introduce innovative products and maintain their competitive edge. Other prominent players in the market include PerkinElmer Inc., Agilent Technologies, Inc., and BGI. Partnerships, collaborations, and acquisitions are common strategies adopted by market players to expand their product portfolio and geographical presence.

The North America Next Generation Sequencing (NGS) market is witnessing significant growth driven by the increasing demand for precision medicine, personalized treatment, and advancements in genomic research. One of the emerging trends in the market is the integration of artificial intelligence and machine learning algorithms with NGS technology to enhance data analysis and interpretation. This trend is expected to revolutionize the way genetic information is utilized in diagnostics, drug discovery, and other applications. The market is also witnessing a rise in the adoption of single-molecule real-time (SMRT) sequencing technology, which offers advantages such as long-read sequencing and real-time data generation. This technology has the potential to enable more comprehensive genomic analysis and improve the accuracy of results.

Another key factor contributing to the growth of the NGS market in North America is the increasing investments in healthcare infrastructure and research initiatives. Academic and research institutes are at the forefront of utilizing NGS technology for genomic studies, leading to a rise in collaborations between academia and industry players. Moreover, the growing focus on biomarker discovery and the development of targeted therapies is driving the demand for NGS in drug discovery and precision medicine applications. This trend is expected to further fuel market growth in the coming years, as pharmaceutical and biotechnology companies leverage NGS technology to accelerate drug development processes and improve patient outcomes.

In terms of market players, the competitive landscape of the North America NGS market is characterized by intense rivalry among key players such as Illumina, Inc., Thermo Fisher Scientific Inc., and Pacific Biosciences of California, Inc. These companies continue to invest in research and development to introduce novel sequencing platforms and expand their product offerings. Additionally, strategic partnerships and collaborations play a vital role in enhancing market presence and driving innovation. Companies like Qiagen, F. Hoffmann-La Roche Ltd, and Oxford Nanopore Technologies are also prominent players in the market, contributing to the diversity of products and services available to end users across various sectors.

Overall, the North America NGS market is poised for substantial growth owing to the increasing applications of genomic sequencing in healthcare, research, and clinical diagnostics. As technology continues to evolve and become more accessible, the market is expected to witness further advancements in data analysis, interpretation, and integration with other healthcare technologies. With a strong emphasis on precision medicine and personalized treatment approaches, the NGS market in North America is set to play a crucial role in shaping the future of genomic research and healthcare delivery.The North America Next Generation Sequencing (NGS) market is positioned for robust growth driven by various factors influencing the industry landscape. The market segmentation based on technology, application, and end user highlights the diversification and widespread adoption of NGS technology across different sectors. Sequencing by Synthesis (SBS) emerges as a prominent technology due to its accuracy and cost-effectiveness, while applications such as diagnostics, drug discovery, and precision medicine continue to propel market expansion. Academic and research institutes stand out as the primary end users, underscoring the significance of NGS technology in advancing genomic studies and biomedical research.

Market players such as Illumina, Inc., Thermo Fisher Scientific Inc., and Pacific Biosciences of California, Inc. lead the competitive landscape, leveraging substantial investments in R&D to drive innovation and maintain market dominance. Strategic collaborations and acquisitions are common tactics deployed by key players to broaden their product portfolio and geographical reach, ensuring sustained growth and a competitive edge in the market. The integration of artificial intelligence and machine learning with NGS technology represents a transformative trend, promising enhanced data analysis capabilities and revolutionizing genetic information utilization in healthcare applications.

The growing focus on precision medicine, personalized treatment, and genomic research advancements underscores the market's potential for further expansion in North America. The increasing investments in healthcare infrastructure and research initiatives pave the way for enhanced utilization of NGS technology in diagnostics, drug discovery, and biomarker exploration. Academic-industry collaborations drive technological advancements and spur innovation, while the adoption of SMRT sequencing technology offers novel opportunities for comprehensive genomic analysis and improved result accuracy. The competitive dynamics among key market players foster a climate of innovation and drive the development of cutting-edge sequencing platforms to meet evolving market demands. As the NGS market continues to evolve and intersect with other healthcare technologies, its pivotal role in shaping the future of genomic research and healthcare delivery in North America becomes increasingly pronounced.

Learn about the company’s position within the industry https://www.databridgemarketresearch.com/reports/north-america-next-generation-sequencing-ngs-market/companies

Frequently Asked Questions About This Report

Is the North America Next Generation Sequencing (NGS) Market currently in the growth or maturity stage? What are the bottlenecks in the North America Next Generation Sequencing (NGS) Market supply chain? What is the expected IRR for investments in the North America Next Generation Sequencing (NGS) Market? What is the impact of Right to Repair laws on the North America Next Generation Sequencing (NGS) Market? How is the North America Next Generation Sequencing (NGS) Market evolving in terms of packaging and delivery? How do high initial costs act as a restraint for the North America Next Generation Sequencing (NGS) Market? What is the influence of social media on North America Next Generation Sequencing (NGS) Market demand? How does the Premiumization trend affect North America Next Generation Sequencing (NGS) Market consumer choices? Which year is expected to witness the highest growth spike in the North America Next Generation Sequencing (NGS) Market? How is Subscription Fatigue affecting North America Next Generation Sequencing (NGS) Market revenue? What is the impact of Total Quality Management (TQM) on North America Next Generation Sequencing (NGS) Market? Which application segment generated the most revenue in 2025? What was the valuation of the application segment in 2025?

Browse More Reports:

Global Core Banking Solutions Market Global Lingerie Market Global Lithium Ion Battery Market Global Point-Of-Care-Testing (POCT) Market Saudi Arabia and U.A.E. Modular Construction Market Global Travel Retail Market Global Hair Accessories Market Global Olive Oil Market Global Seed Market Global Avocado Processing Market Global Dried Fruits Market Global Geographic Information System (GIS) Market Global Hemp Fiber Market Global Laboratory Information Management Systems (LIMS) Market Global Plastic Packaging Market

Contact Us: Data Bridge Market Research US: +1 614 591 3140 UK: +44 845 154 9652 APAC : +653 1251 1002 Email:– [email protected]”